US 12,486,497 B2
F-genotype mumps virus attenuated strain and construction method therefor and application thereof
Dayong Tian, Shanghai (CN); Yajing Zhang, Shanghai (CN); Fengcai Zhu, Shanghai (CN); Zhenfang Fu, Shanghai (CN); Lixia Xie, Shanghai (CN); Yuanbao Liu, Shanghai (CN); Juncheng Ruan, Shanghai (CN); Jinliang Wang, Shanghai (CN); and Qi An, Shanghai (CN)
Assigned to SHANGHAI KING-CELL BIOTECHNOLOGY CO. LTD., Shanghai (CN); and BEIJING CELL-FUSION BIOTECHNOLOGY CO., LTD., Beijing (CN)
Appl. No. 17/755,663
Filed by SHANGHAI KING-CELL BIOTECHNOLOGY CO. LTD., Shanghai (CN); and BEIJING CELL-FUSION BIOTECHNOLOGY CO., LTD., Beijing (CN)
PCT Filed Nov. 3, 2020, PCT No. PCT/CN2020/126248
§ 371(c)(1), (2) Date May 4, 2022,
PCT Pub. No. WO2021/088825, PCT Pub. Date May 14, 2021.
Claims priority of application No. 201911066044.3 (CN), filed on Nov. 4, 2019.
Prior Publication US 2022/0389391 A1, Dec. 8, 2022
Int. Cl. C12N 7/00 (2006.01); A61K 39/165 (2006.01); A61K 39/00 (2006.01)
CPC C12N 7/00 (2013.01) [A61K 39/165 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C12N 2760/18721 (2013.01); C12N 2760/18734 (2013.01)] 9 Claims
OG exemplary drawing
 
1. An F genotype mumps virus attenuated strain, which is mumps virus QS-F-SH2 with the accession number of CCTCC NO: V201950.